Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5863 posts found.

dr_nathwani_770x510

Sanofi name current CMO Dr Ameet Nathwani as new Chief Digital Officer

February 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

French firm Sanofi has appointed pharma veteran Dr Ameet Nathwani to the position of Chief Digital Officer. In his new …
Appointment
scotland

Gilead’s CAR-T therapy Yescarta rejected for NHS use in Scotland

February 12, 2019 Manufacturing and Production, Sales and Marketing CAR-T, Cancer, Gilead, NHS, Scotland, Yescarta, kite pharma

It’s bad news for Scottish patients living with aggressive forms of non-Hodgkin lymphoma (NHL) as it emerges that the Scottish …
News
guernsey-1881254_960_720

Immuno Biotech financial chief found guilty of money laundering

February 12, 2019 Manufacturing and Production David Noakes, Dawson-Ball, GcMAF, Guernsey, Immuno Biotech

Peter Edward Dawson-Ball, the financial head of the Guernsey-based firm immuno Biotech, that sold unlicensed blood product GcMAF, has been …
News
merck-keytruda

Keytruda + Inlyta combo beats Pfizer’s chemotherapy Sutent in renal cell carcinoma

February 12, 2019 Manufacturing and Production, Research and Development Cancer, MSD, Pfizer, inlyta, keytruda, pharma, renal cell carcinoma

New data has been revealed on the efficacy of MSD’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib), showing it …
News
5204602349_c87b204860_z

FDA to crack down on dietary supplements

February 12, 2019 Manufacturing and Production Alzheimer's, Alzheimers, Cancer, Dietary Supplements, FDA, USA, diabetes

The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, …
News
gilead-sciences

Gilead shares drop 4% after failure of NASH drug to meet primary endpoint

February 12, 2019 Manufacturing and Production Gilead, Shares, fatty liver disease, nash, selonsertib

Gilead’s treatment for the progressive fatty liver disease, NASH, has failed to meet its primary goal in a phase 3 …
News
ai_pharmafocus

Solving the drug development problem

February 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, drug discovery, feature, pharma, pistoia alliance

Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique …
Feature

Dame Sally Davis to step down as England’s CMO to become Master of Trinity College, Cambridge

February 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Professor Dame Sally Davies is set to step down from her roles as England’s Chief Medical Officer and as the …
Appointment
pat_smallcombe

Pat Smallcombe appointed chairman of J&J Consumer, EMEA

February 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Johnson & Johnson Consumer has appointed Pat Smallcombe to the position of Company Group Chairman, Europe, Middle East, Africa (EMEA). …
Appointment
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, Merck, Pfizer, falsified medicines, strike, top 10

The strike in Ireland featured twice in this week’s top 10 after Pfizer employees in County Cork lost a dispute …
News
donato_spota

Hansa Biopharma names Donato Spota as new CFO

February 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Swedish firm Hansa Biopharma has appointed Donato Spota as the company’s new Chief Financial Officer (CFO). Spota will succeed current …
Appointment
chimerix_headshots_140x140_michelle-138x138

Chimerix CEO M. Michelle Berrey to stand down as interim Office of Cheif Executive Officer is formed

February 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The North Carolina-based biopharmaceutical company Chimerex has announced that Dr M. Michelle Berrey has resigned from her role as President …
Appointment
harald_fricke

Czech biotech SOTIO appoints experienced immune-oncology doc as new CMO

February 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Czech biotech SOTIO has announced the appointment of Dr Harald Fricke as the firm’s Chief Medical Officer (CMO). Dr Fricke, …
Appointment
robert_friesen

Former Ablynx exec joins Kiadis as Chief Scientific Officer

February 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, appointment, kiadis, pharma

Dutch/US firm Kiadis Pharma revealed that Dr Robert Friesen became its new Chief Science Officer (CSO) as January turned into …
Appointment
lilly_building_with_american_flag_web

Lilly’s Olumiant impresses in twin Phase 3 atopic dermatitis trials

February 5, 2019 Manufacturing and Production, Research and Development Eli Lilly, Olumiant, atopic dermatitis, pharma

Eli Lilly has unveiled new Phase 3 data from two studies into the oral Janus kinase (JAK) inhibitor Olumiant (baricitinib). …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026